As of 2026-07-02, the Fair Value of Cytosorbents Corp (CTSO) is -0.94 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.37 USD, the upside of Cytosorbents Corp is -352.28%.
With the market price of 0.37 USD and our fair value calculation, Cytosorbents Corp (CTSO) is not a good investment. Investing in CTSO stocks now will result in a potential loss of 352.28%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 5Y Avg | |
| Net income | -24.56 | -32.81 | -29.25 | -20.72 | -8.20 | -23.11 |
| YoY growth | -213.27% | -33.59% | 10.86% | 29.16% | 60.43% | -29.28% |
| Market Cap (mil) | 23.48 |
| P/E | |
| Forward P/E |
| EPS | -0.19 |
| Avg earnings growth rate | -29.28% |
| TTM earnings | -11.85 |